Table 2 Demographic characteristics of the placebo group (of the Total vaccinated cohort)
Region | Study number | Age range of infants enrolled at the time of the first placebo dose (weeks) | Gender (%) | Majority race | |
|---|---|---|---|---|---|
Male | Female | ||||
Africa | 444563/013 (Rota-013) | 5–10 | 53.1 | 46.9 | African |
444563/022 (Rota-022) | 5-10 | 50.0 | 50.0 | African | |
102248 (Rota-037) | 2–11 | 51.2 | 48.8 | African heritage/African American | |
Asia | 103478 (Rota-041) | 7–12 | 46.2 | 53.8 | Korean |
103792 (Rota-044) | 8–10 | 54.7 | 45.3 | Indian | |
103992 (Rota-045) | 12–15 | 45.8 | 54.2 | Bangladeshi | |
444563 (Rota-028, −029, −030) | 5 − 20 | 50.9 | 49.1 | Chinese | |
Latin America | 444563/006 (Rota 006) | 6–12 | 50.3 | 49.7 | Mestizo, Mestiza or Mixed |
444563/023 (Rota 023) | 2–13 | 51.7 | 48.3 | Hispanic | |
444563/033 (Rota-033) | 6–12 | 55.6 | 44.4 | Hispanic | |
106260 (Rota-052) | 6 − 13 | 51.0 | 49.0 | American Hispanic or Latino | |
Europe | 444563/003 (Rota 003) | 6-12 | 62.5 | 37.5 | White |
104480 (Rota-048) | 6–12 | 54.0 | 46.0 | White - Caucasian/European heritage | |
102247 (Rota-036) | 5–18 | 51.3 | 48.7 | White/Caucasian | |
106481 (Rota-054) | 5–14 | 50.7 | 49.3 | White - Caucasian/European heritage | |
North America | 444563/005 (Rota 005) | 5-15 | 50.0 | 50.0 | White/Caucasian |